Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/21/2000US6040323 Phosphatase inhibitors and methods of use thereof
03/21/2000US6040322 Medicaments for ameliorating endothelial cell activation
03/21/2000US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
03/21/2000US6040320 Antiinflammatory agent for treating diseases associated with overproduction of inflammatory cytokines, such as rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, and osteoarthritis
03/21/2000US6040319 cyclization; synthesis of cyclooxygenase-2 (COX) inhibitors such as etoricoxib
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040315 Antacid co-polymer of guanidine and polyethylenimine
03/21/2000US6040314 Bicyclic isothiourea derivatives useful in therapy
03/21/2000US6040313 Water-soluble esters of camptothecin compounds
03/21/2000US6040312 Formulations and methods of reducing toxicity of antineoplastic agents
03/21/2000US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/21/2000US6040309 Benzothiophene derivatives useful in therapy
03/21/2000US6040307 Methods ad compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections
03/21/2000US6040306 Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
03/21/2000US6040304 Formulations and methods of reducing toxicity of antineoplastic agents
03/21/2000US6040303 7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
03/21/2000US6040302 1,4-disubstituted piperazines
03/21/2000US6040301 Oral liquid antidepressant solution
03/21/2000US6040300 Administering an anticarcinogenic agents
03/21/2000US6040297 A therapeutic agents treating tumors and retroviral infections including hiv infections
03/21/2000US6040296 Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
03/21/2000US6040294 The compounds have either a sulfhydryl moiety or are reducible disulfides; reducing the side effect of cancer drug
03/21/2000US6040289 Active drug treating obesity
03/21/2000US6040197 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
03/21/2000US6040167 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
03/21/2000US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6040159 Nucleotide sequence of ribonucleotides and optionally deoxyribonucleotides with optionally modified phosphates and hydrogen bonded to itself; targeted against tumor necrosis factor; for antiarthritic agents, antisense agents, viricides
03/21/2000US6040147 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease
03/21/2000US6039981 Itraconazole, phosphoric acid with carriers as fungicides
03/21/2000US6039974 Drugs of multilayer tablets
03/21/2000US6039970 Nasal administering bioactive drugs with hyaluronic acid derivatives, dissolving in dimethyl sulfoxide, adding to mineral oil, ethyl acetate, filtration
03/21/2000US6039969 Immune response modifier compounds for treatment of TH2 mediated and related diseases
03/21/2000US6039967 Intravesical drug delivery system
03/21/2000US6039963 Ceramide compounds, process for their preparation and use
03/21/2000US6039959 Treatment and diagnosis of infections due to helicobacter pylori
03/21/2000US6039945 Administering purified prothrombinase factor to humans
03/21/2000US6039943 Removal of blood from vitreous humor of blood
03/21/2000US6039941 Live vaccine for the treatment of tumor diseases
03/21/2000US6039940 Inherently antimicrobial quaternary amine hydrogel wound dressings
03/21/2000US6039939 N-acyl-hydroxyamino acid esters and their use
03/21/2000US6039932 Administering by mouth or nose
03/21/2000US6039683 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
03/21/2000CA2183731C Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
03/21/2000CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors
03/21/2000CA2132745C Novel cardioprotective agents
03/21/2000CA2062976C Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds
03/21/2000CA2027773C Treatment of shock by cyclodextrins and their derivatives
03/21/2000CA2027743C Diuresis by cyclodextrins and their derivatives
03/21/2000CA2027736C Treatment of male hormone related diseases by cyclodextrins and their derivatives
03/21/2000CA2000468C Piperidinyl benzimidazoles
03/17/2000CA2282234A1 Antitumor activity strengthening method of crude drugs, composition containing crude drug strengthening antitumor activity, evaluating method of antitumor effectiveness by crude drug treatment, and evaluating method of antitumor effectiveness of crude drug
03/17/2000CA2282112A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
03/16/2000WO2000014262A2 Methylation of plasmid vectors
03/16/2000WO2000014244A2 Treatment of cervical cancer
03/16/2000WO2000014228A1 Neutral amino acid transporter and gene thereof
03/16/2000WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000WO2000014217A2 G-motif oligonucleotides and uses thereof
03/16/2000WO2000014100A1 Nocathiacin antibiotic derivatives prepared by microbial biotransformation
03/16/2000WO2000014099A1 Method of preparing form ii crystals of clarithromycin
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO2000014095A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
03/16/2000WO2000014089A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014088A1 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
03/16/2000WO2000014086A1 Chemokine receptor antagonists and methods of use therefor
03/16/2000WO2000014084A1 Substituted dihydrobenzopyrans useful as antiarrhythmic agents
03/16/2000WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO
03/16/2000WO2000014082A1 Diarylmethylidene furan derivatives as drugs with anti-inflammatory, analgesic and chemopreventive properties
03/16/2000WO2000014079A1 Aza-cyclodepsipeptides and their use as antiparasitics
03/16/2000WO2000014070A1 Antimalarial compounds
03/16/2000WO2000014067A1 Piperidine derivatives
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/16/2000WO2000014065A1 Kappa agonist compounds and pharmaceutical formulations thereof
03/16/2000WO2000014064A2 Gaba uptake inhibitors having a pyrrolidine structure
03/16/2000WO2000014063A1 Therapeutic compounds and methods
03/16/2000WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000WO2000013712A2 Methods and compositions for the prevention or treatment of cancer
03/16/2000WO2000013709A2 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
03/16/2000WO2000013708A1 Methods for treating or preventing viral infections and associated diseases
03/16/2000WO2000013707A1 Preventives/remedies for multiple organ failure
03/16/2000WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000WO2000013697A1 Tear grass-derived antibacterial agent and process for producing the same
03/16/2000WO2000013696A1 Composition for improving mental capabilities in mammals
03/16/2000WO2000013692A1 Ophthalmic compositions and process of using
03/16/2000WO2000013691A2 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
03/16/2000WO2000013690A1 Exocyclic-phosphoethanolamines
03/16/2000WO2000013689A1 Methods and compositions for increasing intestinal absorption of fats
03/16/2000WO2000013687A2 Sustained release ranolazine formulations
03/16/2000WO2000013686A2 Sustained release ranolazine formulations
03/16/2000WO2000013685A1 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors
03/16/2000WO2000013684A2 Pharmaceutical composition and method for treatment of inflammation
03/16/2000WO2000013683A2 Novel nitrophenylaziridine compounds and their use as prodrugs
03/16/2000WO2000013682A2 4-quinolinemethanol derivatives as purine receptor antagonists.(ii)
03/16/2000WO2000013681A2 4-quinolinemethanol derivatives as purine receptor antagonists (i)
03/16/2000WO2000013677A1 Nanogel networks and biological agent composition thereof
03/16/2000WO2000013675A1 Methazolamide compositions and method of use
03/16/2000WO2000013674A1 Dosage form comprising therapeutic formulation
03/16/2000WO2000013672A1 New solid dose form of nanoparticulate naproxen
03/16/2000WO2000013671A1 Immediate release tablet
1 ... 6347 6348 6349 6350 6351 6352 6353 6354 6355 6356 6357 6358 6359 6360 6361 6362 6363 6364 6365 6366 6367 ... 7860